NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...

NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...

More than a month after filing for Chapter 11 bankruptcy, NanoString Technologies has agreed to be acquired by the healthcare investment firm Patient Square Capital for $220 million pending approval ...

Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. The ...

NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Shares of Seattle-based publicly traded biotech company NanoString ...

NanoString Technologies (NASDAQ:NSTG) shares plunged over 46% premarket on Monday after the life science firm and certain of its subsidiaries voluntarily initiated a chapter 11 bankruptcy process to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Research device company ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...

Inclusion of Abcam validated antibodies in CosMx curated protein panel provides the first high-plex spatial multiomic solution at single-cell and subcellular resolution SEATTLE & CAMBRIDGE, United ...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into ...

Mr. Garland is a senior executive with more than 25 years of experience in healthcare and life sciences technologies that serve customers in the discovery, translational and clinical markets. Most ...